AlphaGrep UK
MDGL icon

AlphaGrep UK’s Madrigal Pharmaceuticals MDGL Stock Holding History

AlphaGrep UK’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$324K Buy
+642
New +$339K 0.1% 451
2026
Q2 		– Sell
-758
Closed -$397K – 867
2026
Q1 		$397K Buy
+758
New +$362K 0.11% 362

Other funds holding MDGL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

AlphaGrep UK's MDGL Position: Q3 2026 in Review

AlphaGrep UK opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 642 shares worth $324K. The stake represents 0.1% of the portfolio and ranks #451 among its holdings. This is a return to the name: AlphaGrep UK previously reported a position in MDGL as recently as Q1 2026.

AlphaGrep UK first reported a position in MDGL in Q1 2026 and has held it in 2 quarters since. The position peaked at $397K in Q1 2026. 332 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • AlphaGrep UK held 642 shares of Madrigal Pharmaceuticals worth $324K as of Q3 2026.
  • Madrigal Pharmaceuticals was a new AlphaGrep UK position in Q3 2026.
  • Madrigal Pharmaceuticals made up 0.1% of AlphaGrep UK's portfolio in Q3 2026, its #451 holding.
  • AlphaGrep UK first reported a position in Madrigal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • AlphaGrep UK's Madrigal Pharmaceuticals position peaked at $397K in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.